Hyperinsulinism in a child presenting with cardiac ischemia and bradycardia

Majid Al-Fayyadh1, Ziad Bulbul1, Waleed Al Maneea1

  • 1Heart Centre, King Faisal Specialist Hospital & Research CentreSaudi Arabia.

Insights

Hypoglycemia can cause heart rhythm disturbances and depressed ventricular function in children. Prompt glucose administration resolved these cardiac issues, highlighting its importance in unexplained pediatric cardiac events.

Area of Science:

  • Pediatric Cardiology
  • Endocrinology
  • Electrophysiology

Background:

  • Sinus node dysfunction and ventricular dysfunction can present with varied etiologies in pediatric patients.
  • Hypoglycemia is a critical metabolic derangement that can have systemic effects, including cardiovascular manifestations.
  • The interplay between metabolic disturbances and cardiac function in children requires further elucidation.

Purpose of the Study:

  • To investigate the potential causal link between hypoglycemia and cardiac abnormalities in a pediatric patient.
  • To determine the efficacy of glucose administration in resolving hypoglycemia-induced cardiac dysfunction.

Main Methods:

  • Case report of a 5-year-old boy with suspected sinus node dysfunction.
  • Clinical assessment including evaluation of arrhythmia, mitral valve regurgitation, and ventricular function during a hypoglycemic episode.
  • Monitoring of cardiac function and rhythm following glucose infusion.

Main Results:

  • The patient presented with arrhythmia and moderate mitral valve regurgitation.
  • Ventricular function was depressed during the hypoglycemic episode.
  • Cardiac abnormalities resolved completely after intravenous glucose infusion.

Conclusions:

  • Hypoglycemia should be considered a potential cause of unexplained cardiac manifestations, including rhythm disturbances and depressed ventricular function, in pediatric patients.
  • Glucose infusion is an effective treatment for resolving hypoglycemia-induced cardiac dysfunction.
  • Early recognition and management of hypoglycemia are crucial in preventing or reversing cardiac complications.

Related Concept Videos

Decreased pulse rate01:14

Decreased pulse rate

Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
1.1K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.4K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
3.2K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.3K
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
2
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
9